Vamil Divan
Stock Analyst at Guggenheim
(4.74)
# 633
Out of 4,355 analysts
957
Total ratings
57.2%
Success rate
11.5%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Reiterated: Buy | $43 | $27.66 | +55.46% | 12 | May 28, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $32 | $21.04 | +52.09% | 7 | May 26, 2026 | |
| SVRA Savara | Reiterated: Buy | $11 | $5.20 | +111.54% | 9 | May 12, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $40 → $37 | $7.38 | +401.36% | 7 | May 12, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $124 | $78.51 | +57.94% | 19 | May 10, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $56 | $35.52 | +57.66% | 13 | May 10, 2026 | |
| INSM Insmed | Reiterated: Buy | $230 → $226 | $106.91 | +111.39% | 15 | May 7, 2026 | |
| PFE Pfizer | Reiterated: Buy | $36 | $26.18 | +37.51% | 116 | May 6, 2026 | |
| STO: VICO Vicore Pharma Holding AB (publ) | Reiterated: Buy | kr 38.00 | $11.70 | +224.79% | 2 | May 6, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $56 | $47.18 | +18.69% | 26 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $351 → $340 | $336.79 | +0.95% | 7 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $118.72 | +17.92% | 47 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 | $217.72 | +14.37% | 128 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $266 | $225.33 | +18.05% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $6.25 | +76.00% | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.81 | +109.97% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $1.83 | +282.51% | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.25 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | $8.80 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $0.705 | n/a | 4 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $6.75 | n/a | 1 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.2309 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $26 | $7.21 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,105.00 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $93.01 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.16 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $234.48 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.56 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $21.66 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $42.19 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $3.78 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $66.54 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $614.78 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $141 | $43.67 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $447.54 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $16.06 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $29.99 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $158.30 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $21.46 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $37.25 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.816 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.57 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $35.32 | n/a | 55 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $59 → $55 | $57.18 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $28.38 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $90.66 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $12.41 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $29 | $3.13 | n/a | 11 | Mar 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $196.00 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $1.08 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $3.97 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $162.96 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $134.43 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $135.53 | n/a | 1 | Mar 5, 2013 |
Assembly Biosciences
May 28, 2026
Reiterated: Buy
Price Target: $43
Current: $27.66
Upside: +55.46%
Jade Biosciences
May 26, 2026
Reiterated: Buy
Price Target: $32
Current: $21.04
Upside: +52.09%
Savara
May 12, 2026
Reiterated: Buy
Price Target: $11
Current: $5.20
Upside: +111.54%
Unicycive Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $7.38
Upside: +401.36%
ANI Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $124
Current: $78.51
Upside: +57.94%
Vera Therapeutics
May 10, 2026
Reiterated: Buy
Price Target: $56
Current: $35.52
Upside: +57.66%
Insmed
May 7, 2026
Reiterated: Buy
Price Target: $230 → $226
Current: $106.91
Upside: +111.39%
Pfizer
May 6, 2026
Reiterated: Buy
Price Target: $36
Current: $26.18
Upside: +37.51%
Vicore Pharma Holding AB (publ)
May 6, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: $11.70
Upside: +224.79%
Travere Therapeutics
May 4, 2026
Reiterated: Buy
Price Target: $56
Current: $47.18
Upside: +18.69%
May 3, 2026
Maintained: Hold
Price Target: $351 → $340
Current: $336.79
Upside: +0.95%
May 3, 2026
Reiterated: Buy
Price Target: $140
Current: $118.72
Upside: +17.92%
Apr 30, 2026
Reiterated: Buy
Price Target: $249
Current: $217.72
Upside: +14.37%
Apr 20, 2026
Reiterated: Buy
Price Target: $240 → $266
Current: $225.33
Upside: +18.05%
Apr 16, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $6.25
Upside: +76.00%
Mar 20, 2026
Maintained: Buy
Price Target: $8
Current: $3.81
Upside: +109.97%
Jul 13, 2025
Maintained: Buy
Price Target: $6 → $7
Current: $1.83
Upside: +282.51%
May 29, 2025
Maintained: Hold
Price Target: n/a
Current: $11.25
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: $8.80
Upside: n/a
Mar 19, 2025
Maintained: Buy
Price Target: $6 → $5
Current: $0.705
Upside: n/a
Oct 1, 2024
Initiated Coverage: Buy
Price Target: $10
Current: $6.75
Upside: n/a
May 6, 2024
Maintained: Hold
Price Target: n/a
Current: $0.2309
Upside: n/a
Jun 15, 2023
Maintained: Buy
Price Target: $50 → $26
Current: $7.21
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,105.00
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $93.01
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $6.16
Upside: n/a
Jun 27, 2022
Maintained: Buy
Price Target: $49
Current: $234.48
Upside: n/a
Jun 21, 2022
Maintained: Buy
Price Target: $15
Current: $6.56
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $21.66
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $42.19
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: $20 → $10
Current: $3.78
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $66.54
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $614.78
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $141
Current: $43.67
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $447.54
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $16.06
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $29.99
Upside: n/a
May 4, 2022
Maintained: Hold
Price Target: $95
Current: $158.30
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $21.46
Upside: n/a
May 7, 2021
Maintained: Buy
Price Target: $37
Current: $37.25
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $0.816
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $3.57
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $35.32
Upside: n/a
May 29, 2019
Maintained: Hold
Price Target: $59 → $55
Current: $57.18
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $28.38
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $90.66
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $12.41
Upside: n/a
Mar 20, 2017
Upgraded: Hold
Price Target: $29
Current: $3.13
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $196.00
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $1.08
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $3.97
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $162.96
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $134.43
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $135.53
Upside: n/a